Zai Lab Ltd (ZLAB): Depreciation & Amortization
$15.01M
Year ended 2025-12-31
$15.93M
Trailing 12 months to 2026-06-30
+22.2%
3-year compound annual growth
+26.5%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $15.01M | +26.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $11.86M | +31.3% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $9.03M | +9.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $8.23M | +26.8% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $6.49M | +39.8% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $4.64M | +23.2% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $3.77M | +128.2% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $1.65M | +201.1% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $548.0K | n/a | 2020-04-29, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $15.01M | +26.6% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $13.84M | -2.6% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $60.74M | +39.5% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $5.43M | -10.6% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $3.06M | +48.3% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $24.24M | +2.6% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $13.31M | +7.8% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $15.27M | +12.1% |
| MannKind Corp (MNKD) | 2025-12-31 | $12.28M | +66.7% |
Compare ZLAB, NATR, TVTX, BBIO side by side · Screen every company in Pharmaceutical Preparations ↗